Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Julie Winter

Julie Winter

Julie Winter is Vice President of Business Development at Kyverna Therapeutics. Prior to Kyverna she was VP Business Development at PaxVax, Inc., where she led major corporate transactions, culminating in the sale of PaxVax to Emergent Biosolutions in 2018 for $270 million.

OverviewStructured DataIssuesContributorsActivity
No article content yet.

Timeline

No Timeline data yet.

Current Employer

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more people like Julie Winter

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.